Pharmafile Logo

Event Logistics

- PMLiVE

NICE blocks second Alexion rare disease drug in a week

Says high cost and “considerable uncertainties” over long-term benefits prohibit routine NHS use

- PMLiVE

2016: The year when deal-makers took stock?

Merger-mania and asset swaps slowed and joint ventures were back in fashion

- PMLiVE

Therachon strengthens management team

Dr Hans Schikan, Dr Richard Porter and Dr Jeffrey Stavenhagen join

- PMLiVE

Astellas names Linda Friedman as EVP, general counsel

She is due to take up the role on 1 April

- PMLiVE

New guide to improve cancer control published in EU

Outlines recommendations to boost quality of life and reduce financial burden

- PMLiVE

From first conversation to the cover of TimeOut London: #Kisses4wishes to support Rays of Sunshine

As a business that works with healthcare and pharma companies, it’s not often that we get the opportunity to design the cover for Time Out London, so we jumped at...

Blue Latitude Health

- PMLiVE

Merck BACE inhibitor adds to litany of Alzheimer’s trial failures

Interim data shows “virtually no chance” of clinical success for verubecestat

Eli Lilly HQ

Lilly claims first place for JAK inhibitor Olumiant in EU

EMA approves once-daily rheumatoid arthritis drug ahead of Pfizer’s Xeljanz

A butterfly flaps its wings

A series of articles in The Lancet may change our world

- PMLiVE

Hanover Health bolsters PR leadership team

Alexander Davies, Emma Gorton and Sarah Ghabina join the agency’s London office

- PMLiVE

Life boosts client services and creative teams

Amanda Walker, Katy Pulsford, Ryah Johnson and Faye Donohue join

- PMLiVE

Danone looks at the science behind parental love

'What is love?' campaign is part of its ongoing 'Mum meets Science' platform

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links